ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Madopar 125, Kapseln - 100 Kapsel(n)
38096036 Roche Pharma (Schweiz) AG
Madopar 125, Kapseln27.06.1973
Original27.06.1973
Levodopa and Decarboxylase Inhibitor (N04BA02)12.02.2004
WHO-DDD 
01.08.100 Kapsel(n)
01.08. 
B  
Yes 
IPCI
11.01No
    
10 %28.35
7680380960366Synthetika
632622 
Composition
levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum K 90, magnesii stearas, Kapselhülle: E 172 (rubrum), E 171, E 132, gelatina, Drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Benserazide25 mg
Levodopa100 mg
BAG: Active AgentDose
Benserazide25 mg
Levodopa100 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Ammoniae Solutio28  
Cellulosum Microcristallinum  
E 132 color.
E 171 color.
E 172 color.
Gelatina  
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Per Centum  
Povidonum K90  
Pro Capsula  
Propylenglycol  
Talcum  
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home